Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

Novo Nordisk A/S114 enrolled

Overview

This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.

Study Type

OBSERVATIONAL

Enrollment

114

Conditions

Diabetes Diabetes Mellitus, Type 2

Interventions

insulinDRUG

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type 2 diabetes patients * Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections * HbA1c greater than or equal to 8.0% Exclusion Criteria: * Patients not performing glycaemia self-measurements * Secondary diabetes * Requirement of or use of an insulin pump * Treatment with corticoids

Locations (1)

Unnamed facility

Paris La Défense, France

Outcomes

Primary Outcomes

Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

Time frame: After 3 months

Secondary Outcomes

Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

Time frame: After first 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.